| Name | Title | Contact Details |
|---|---|---|
Chad Hixon |
Director of Talent Acquisition | Profile |
Jill Collins |
Director, People | Profile |
David First |
Chief People Officer | Profile |
Armon Sharei |
Chief Executive Officer | Profile |
Cydan Development is an orphan drug accelerator that identifies and de-risks programs with therapeutic and commercial potential.
DNA Script was created to revolutionize DNA synthesis with enzymes` Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation` The integration of these innovations has resulted in SYNTAX™️, the world’s first benchtop DNA printer powered by enzymatic technology` With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine`
Center des Research Hotel-Dieu, U Laval is a Qubec, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Imerjent is a Wilsonville, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. With its Immune Repertoire Capture™ (IRC™) technology, Atreca has an unparalleled insight into how cancer patients` immune responses can drive better clinical outcomes. Atreca was founded by scientists, industry experts, and investors who share the vision that unlocking the immune response of today`s patients is the key to creating a new generation of therapies. Atreca is looking for talented, entrepreneurial people who are dedicated to making a positive impact on human health.